penn medicine
penn surgery
penn surgery home penn surgery clinical penn surgery education penn surgery research penn surgery administration

Carla S. Fisher, MD, FACS
Endocrine and Oncologic Surgery

 
  • Profile Home
  • Appointments
  • Education
  • Societies
  • Research
  • Publications
  • Awards

Administrative Office:
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
10th floor South
Philadelphia, PA  19104
Administrative Assistant: Ronda Watson
Administrative Telephone: 215-615-6833
Administrative Fax: 215-615-0555

Clinical Office:
Perelman Center for Advanced Medicine
Rena Rowan Breast Center
Abramson Cancer Center
3rd Floor West
3400 Civic Center Boulevard
Philadelphia, PA 19104
Patient Appointment: 215-615-5858 option 3
Clinical Telephone: 215-615-6833
Clinical Fax: 215-615-0555

Contact Information (internal use only)

carla.fisher@uphs.upenn.edu

 

Dr. Carla Fisher is a fellowship-trained breast surgeon who specializes in all aspects of both benign and malignant breast disease. She is also the program director for the University of Pennsylvania Fellowship Program.  She sees patients at the Rena Rowan Breast Center housed in the Abramson Cancer Center along with a multidisciplinary team that includes medical oncology, radiation oncology, breast radiology, and surgical nurse practitioners.

Dr. Fisher completed her undergraduate studies at the Pennsylvania State University and received her medical degree from the University of Pennsylvania School of Medicine. She fulfilled a general surgery residency at the Medical University of South Carolina in Charleston and a fellowship in breast oncology at the Washington University School of Medicine.

 
Faculty Appointments
2011 - present Assistant Professor of Surgery at HUP
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
 
2012 - 2016 General Surgeon, Philadelphia Veteran's Affairs Medical Center
 
Hospital and Administrative Appointments
2015 - present Associate Clerkship Director, SU200, Perelman School of Medicine
 
2013 - present Program Director for Breast Surgery Fellowship
Hospital of the University of Pennsylvania
 
2012 - 2013 Assistant Program Director Breast Surgery Fellowship
Hospital of the University of Pennsylvania
 
2012 - present General Surgeon, Philadelphia VAMC
 
2011 - present Attending Surgeon
Hospital of the University of Pennsylvania Philadelphia, Pennsylvania
 
Other Appointments
1999 - 2001 Neuroscience Basic Researcher
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania
 
Education/Training
2001 - 2005 MD - University of Pennsylvania
Philadelphia, Pennsylvania
 
1995 - 1999 BS - Penn State University
University Park, Pennsylvania
(Biochemistry and Molecular Biology with Honors)
 
Postgraduate Training and Fellowship Appointments
2010 - 2011 Surgical Fellowship in Breast Oncology
Washington University
Saint Louis, Missouri
 
2005 - 2010 Residency in General Surgery
Medical University of South Carolina
Charleston, South Carolina
 
Memberships/Societies
 
National
2015 - present Association of Surgical Education
 
2014 - present Association of Women Surgeons
 
2011 - present Association of Academic Surgeons
 
2010 - present Society of Surgical Oncologists
 
2010 - present American Society of Breast Surgeons
 
2009 - present American College of Surgeons
 
Research Current Research
Research Publications, peer reviewed (print or other media)
  1. Fisher CS, Cole DJ, Mitas M, Garrett-Meyer E, Metcalf JS, Gillanders WE, Mikhitarian K, Urist MM, Mann GB, Doherty G, Herrmann VM, Hill AD, Eremin O, El-Sheemy M, Orr RK, Valle AA, Henderson MA, Dewitty RL, Sugg SL, Frykberg E, Yeh K, Bell RM, Baker MK: Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: A final analysis of a prospective multi-institutional cohort study. Annals of Surgical Oncology 17(Suppl 3): 312-320, October 2010.
  2. Fisher CS, Klimberg VS, Khan S, Gao F, Margenthaler JA: Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS. Annals of Surgical Oncology 18(11): 3155-3159, October 2011.
  3. Fisher CS, Margenthaler JA: A look into the ductoscope: Its role in pathologic nipple discharge. Annals of Surgical Oncology 18(11): 3187-3191, October 2011.
  4. Fisher CS, Mushawah FA, Cyr AE, Gao F, Margenthaler JA: Ultrasound-guided lumpectomy for palpable breast cancers. Annals of Surgical Oncology 18(11): 3198-3203, October 2011.
  5. Fisher CS, Ma CX, Gillanders WE, Aft RL, Eberlein TJ, Gao F, Margenthaler JA: Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response. Annals of Surgical Oncology 19(1): 253-258, January 2012.
  6. Fisher CS, Wachtel MS, Margenthaler JA: Outcomes for patients who develop both breast and colorectal cancer. Annals of Surgical Oncology 19(1): 242-248, January 2012.
  7. Elmore L, Myckatyn TL, Gao F, Fisher CS, Atkins J, Martin-Dunlap TM, Margenthaler JM: Reconstruction Patterns in a Single Institution Cohort of Women Undergoing Mastectomy for Breast Cancer. Annals of Surgical Oncology 19(10): 3223-9, Oct 2012.
  8. Showalter SL, Brown JC, Cheville AL, Fisher CS, Sataloff D, Schmitz K : Lifestyle Risk Factors Associated with Arm Swelling among Women with Breast Cancer. Annals of Surgical Oncology October 2012.
  9. Fisher CS, Martin-Dunlap T, Ruppel MB, Gao F, Atkins J, Margenthaler JA: Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age. Annals of Surgical Oncology 19: 3246-3250, 2012.
  10. Atkins JJ, Appleton C, Fisher CS, Gao F, Margenthaler JM: Which Imaging Modality is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer? Journal of Oncology 2013, February 2013.
  11. Fracol M, Xu S, Mick R, Fitzpatrick E, Nisenbaum H, Roses R, Fisher C, Tchou J, Fox K, Zhang P, Czerniecki BJ: Response to HER-2 Pulsed DC1 Vaccines is Predicted by BothHER-2 and Estrogen Receptor Expression in DCIS. Annals of Surgical Oncology 20(10): 3233-9, October 2013.
  12. Edwards C, Margenthaler JM, Fisher CS: Margin index: a useful tool for the breast surgeon? Journal of Surgical Research 190(1): 164-9, July 2014.
  13. Offodile AC, Chatterjee A, Vallejo S, Fisher CS, Tchou JC, Guo L: A Cost-Utility Analysis of the Use of Preoperative Computed Tomographic-Angiography in Abdomen-Based Perforator Flap Breast Reconstruction. Plast Reconstr Surg December 2014.
  14. Pyfer B, Chatterjee A, Tchou J, Czerniecki B, Fisher C: Early Postoperative Outcomes in Breast Conservation Surgery versus Simple Mastectomy with Implant Reconstruction: A NSQIP Analysis of 11,645 Patients. Ann Surg Onc 23: 92-8, Jan 2015.
  15. Datta J, Berk E, Xu S, Fitzpatrick E, Rosemblit C, Lowenfeld L, Goodman N, Lewis D, Zhang PJ, Fisher CS, Roses RE, DeMichele A, Czerniecki BJ: Anti-HER2 CD4+ T-helper Type 1 Response is a Novel Immune Correlate to Pathologic Response following Neoadjuvant Therapy in HER2-Positive Breast Cancer. Breast Cancer Research 17, May 2015.
  16. Chatterjee A, Kosowksi T, Pyfer B, Fisher CS, Tchou J, Maddali S: A Cost-Utility Analysis Comparing the Sartorius Versus the Rectus Femoris Flap in the Treatment of the Infected Vascular Groin Graft Wound. Plast Reconstr Surg 135: 1707-1714, June 2015.
  17. Chatterjee A, Pyfer B, Czerniecki B, Rosenkranz K, Tchou J, Fisher C: Early postoperative outcomes in lumpectomy versus simple mastectomy. J Surg Res 198(1): 143-8, Sept 2015.
  18. Chatterjee A, Pyfer B, Chen L, Czerniecki B, Tchou J, Fisher C: Resident and Fellow participation in Breast Surgery: An ACS-NSQIP Clinical Outcomes Analysis. JACS 221: 988-94, Nov 2015.
  19. Keating J, Tchou J, Okusanya O, Fisher C, Batiste R, Jiang J, Kennedy G, Nie S, Singhal S: Identification of Breast Cancer Margins Using Intraoperative Near-Infrared Imaging. J Surg Oncol 113(5): 508-14, Apr 2016.
  20. De La Cruz L, Blankenship SA, Chatterjee A, Geha R, Nocera N, Czerniecki BJ, Tchou J, Fisher CS: Outcomes after Oncoplastic Breast-Conserving Surgery in Breast Cancer Patients: A Systematic Literature Review. Ann Surg Oncol 2016.
  21. Fisher CS: Addition of Anti-Estrogen Therapy to Anti-HER2 Dendritic Cell Vaccination Improves Regional Nodal Immune Response and Pathologic Complete Response Rate in Patients with ERpos/HER2pos Early Breast Cancer. OncoImmunology 2016.
Research Publications, peer-reviewed reviews
  1. Fisher CS, Freedman GM, Tchou J: Can We Identify a Subset of Patients with DCIS that can be Treated by Wide Excision Alone? Current Cancer Therapy Review 2012.
 
Publications
Abstracts
  1. Martin-Dunlap T, Fisher CS, Margenthaler JA: Patient Factors Predictive of Unilateral Mastectomy and Contralateral Prophylactic Mastectomy. Presented at the American Society of Breast Surgeons Annual Meeting in Phoenix, Arizona April 2012.
  2. Wilson NP, Wilson FP, Freedman GM, Fisher CS: Radiation Therapy in Patients with Breast Cancer and Connective Tissue Disease. American Society of Breast Surgeons Meeting May 2014.
  3. Offodile AC, Chatterjee A, Vallejo S, Fisher CS, Tchou JC, Guo L: A Cost-Utility Analysis of the Use of Preoperative Computed Tomographic-Angiography in Abdomen-Based Perforator Flap Breast Reconstruction. Plast Reconstr Surg December 2014.
  4. A Chatterjee, CS Fisher: A Cost-Utility Analysis Comparing the Sartorius Versus the Rectus Femoris Flap in the Treatment of the Infected Vascular Groin Graft Wound. PRS 2015.
  5. J Datta, E Berk, S Xu, E Fitzpatrick, C Rosemblit, L Lowenfeld, N Goodman, D Lewis, PJ Zhang, CS Fisher, RE Roses, A DeMichele, BJ Czerniecki: Anti-HER2 CD4+ T-helper Type 1 Response is a Novel Immune Correlate to Pathologic Response following Neoadjuvant Therapy in HER2-Positive Breast Cancer. Breast Cancer Research 2015.
  6. De La Cruz L, Chatterjee A, Czerniecki B, Fisher CS: Outcomes after Oncoplastic Breast-Conserving Surgery in Breast Cancer Patients: A Systematic Literature Review. Presented at the American Society of Breast Surgeons Meeting April  2016.
  7. Chatterjee A, Offodile II A, Losken A, Graham R, Chen L, Fisher C, Czerniecki B : A cost-utility analysis comparing oncoplastic breast surgery to standard lumpectomy in large breasted women. Plastic Surgery Research Council  2016.
Editorials, Reviews, Chapters, including participation in committee reports (print or other media)
  1. Schwartz T, Fisher CS: Sentinel lymph node biopsy after Neoadjuvant Chemotherapy for Patients with Axillary Metastases: Can we avoid the unavoidable? Ann Surg Oncol 2016.
Alternative Media
  1. Pearson K: Breast cancer study: Patients may be too quick to have double mastectomy  Huffington Post November 29 2012 Notes: Dr. Fisher quoted in this on-line article.
  2. Carla S Fisher, quoted: Study Suggests Breast Cancer Patients Who Undergo Double Mastectomy Don't Have Better Survival Rates. CBS local news 2014.
 
Awards
 
 
 
 
 
 
 
 
 
 

Dr. Carla Fisher

 
footer Terms of Use Legal Disclaimer Site Map Contact Us Financial Assistance About Penn Medicine Privacy Statement
penn medicine